`
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`APPLICATION NO.
`
`: 8,865,190 B2
`: 14/231971
`
`DATED
`
`INVENTOR(S)
`
`: October 21, 2014
`
`: John R. Plachetka
`
`Page 1 0f1
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below:
`
`On the Title page, item (56) References Cited - U.S. Patent Documents, delete the 54th reference on
`
`page 2 “6,126,816 A 10/2000 Ruiz, Jr.”.
`
`On the Title page, item (56) References Cited - Foreign Patent Documents, insert --JP 2005-145894
`6/2005--.
`
`On the Title page, item (56) References Cited - Other Publications, insert --Goldstein et al., “PA32540
`
`(Enteric-coated aspirin 325 mg + immediate-release omeprazole 40mg) is associated with significantly
`
`fewer gastric ulcers and significantly less endoscopic erosive esophagitis than
`
`enteric-coated aspirin (EC-ASA) alone: Results of two phase 3 studies,” The American Journal of
`
`Gastroenterology, vol. 107, Suppl. 1, pp. 853-854, 2012.--.
`
`On the Title page, item (56) References Cited - Other Publications, insert --Miner et al., “Clinical trial:
`
`evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the
`
`fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500
`
`mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase 1 study in healthy
`
`volunteers,” Aliment. Pharmacol. Ther. , 32(3):414-424, 2010.--.
`
`Signed and Sealed this
`
`Third Day of February, 2015
`
`WMZKLZL.
`
`Michelle K. Lee
`
`Deputy Director ofthe United States Patent and Trademark Oflice
`
`